Resources Contact Us Home
Humanized anti-CD70 binding agents and uses thereof

Image Number 17 for United States Patent #8067546.

Disclosed are CD70 binding agents, such as humanized anti-CD70 antibodies and fragments and derivatives, that exert a cytotoxic, cytostatic or immunomodulatory on CD70 expressing cells, as well as pharmaceutical compositions and kits comprising the antibody, fragment or derivative. Also disclosed are methods for the treatment of CD70-expressing cancers and immunological disorders, comprising administering to a subject the CD70 binding agents or pharmaceutical compositions.

  Recently Added Patents
2,4-disubstituted pyrimidines useful as kinase inhibitors
System and method for supporting fibre channel over ethernet communication
Semiconductor process
Dynamic learning method and adaptive normal behavior profile (NBP) architecture for providing fast protection of enterprise applications
Peer-to-peer, internet protocol telephone system with proxy interface for configuration data
Estimating optical characteristics of a camera component using sharpness sweep data
Permanent magnet axial field zeeman slower
  Randomly Featured Patents
Apparatus for damping vibrations
Memory device and method having low-power, high write latency mode and high-power, low write latency mode and/or independently selectable write latency
Receiver pin
Polyfluoroether based polymers
IT analysis integration tool and architecture
Capacitor and method for manufacturing the same
Interface card and CTI system applying interface card
Melatonin compositions and uses thereof
Folding chairs
Method of making a permanent magnet field pole for a direct current dynamoelectric machine